ResearcherHeidelberg UniversityNo recent work listed
Anne Katrin Berger
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 5
- Poly(ADP-ribose) polymerase inhibition in pancreatic cancer. Co-author DOI 10.1002/gcc.22932↗
- Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response. First author DOI 10.1158/1078-0432.ccr-17-2180↗
- High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrosp… Co-author DOI 10.1016/j.pan.2017.04.012↗
- Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older… Co-author DOI 10.1186/s12876-017-0709-3↗
- Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): a retrospective cohort study at the National Center for Tumor Disea… Co-author DOI 10.1016/j.pan.2014.03.004↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dirk Jäger · 5 shared papers, 2014–2021 · strength 0.40
- Paper Poly(ADP-ribose) polymerase inhibition in pancreatic cancer. DOI 10.1002/gcc.22932↗
- Paper Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the … DOI 10.1186/s12876-017-0709-3↗
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Christoph Springfeld · 5 shared papers, 2014–2021 · strength 0.40
- Paper Poly(ADP-ribose) polymerase inhibition in pancreatic cancer. DOI 10.1002/gcc.22932↗
- Paper Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the … DOI 10.1186/s12876-017-0709-3↗
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Hans Martin Singh · 2 shared papers, 2017–2021 · strength 0.21
- Peter J. Bailey · 1 shared paper, 2021 · strength 0.14
- John P. Neoptolemos · 1 shared paper, 2021 · strength 0.14
- Jens Thomas Siveke · 1 shared paper, 2021 · strength 0.14
- Wilko Weichert · 2 shared papers, 2017–2018 · strength 0.13
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Paper Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correla… DOI 10.1158/1078-0432.ccr-17-2180↗
- Martin Ronald Sprick · 2 shared papers, 2017–2018 · strength 0.13
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Paper Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correla… DOI 10.1158/1078-0432.ccr-17-2180↗
- Alexander Muckenhuber · 2 shared papers, 2017–2018 · strength 0.13
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Paper Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correla… DOI 10.1158/1078-0432.ccr-17-2180↗
- Andreas Trumpp · 2 shared papers, 2017–2018 · strength 0.13
- Paper High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer … DOI 10.1016/j.pan.2017.04.012↗
- Paper Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correla… DOI 10.1158/1078-0432.ccr-17-2180↗
- Marcus Bahra · 1 shared paper, 2018 · strength 0.06
- Anna Melissa Schlitter · 1 shared paper, 2018 · strength 0.06
- Iréne Esposito · 1 shared paper, 2018 · strength 0.06
- Helmut Friess · 1 shared paper, 2018 · strength 0.06
- Carsten Denkert · 1 shared paper, 2018 · strength 0.06
- Albrecht Stenzinger · 1 shared paper, 2018 · strength 0.06
- Jens Werner · 1 shared paper, 2018 · strength 0.06
- Günter Klöppel · 1 shared paper, 2018 · strength 0.06
- Guralp Onur Ceyhan · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.